Table 1

Critically ill patients treated with colistin: clinical characteristics and outcome

Patient
Age (years)
Sex
APACHE II score
Underlying disease
Infection
Pathogen
Response, outcome

1
34
M
21
Trauma, ARDS
VAP
P. aeruginosa
Initial response, Death
2
22
M
17
Trauma
VAP
P. aeruginosa
Response
3
27
M
14
Trauma
VAP
P. aeruginosa
Response
4
36
F
23
Burns, MOF (three organs)
VAP
P. aeruginosa
No response, death
5
25
F
22
Trauma, ARDS
VAP
P. aeruginosa
No response, death
6
47
M
13
Trauma
VAP
P. aeruginosa
Response
7
64
M
17
Trauma
VAP
P. aeruginosa
Response
8
52
F
16
Trauma
VAP
P. aeruginosa
Response
9
29
M
26
Pancreatitis, MOF (three organs)
VAP
P. aeruginosa
Initial response, death
10
38
M
14
Subarachnoid hemorrhage
VAP
P. aeruginosa
Response
11
66
M
28
Head and neck cancer, surgery, MOF (three organs)
VAP
P. aeruginosa
No response, death
12
34
F
16
Trauma
VAP
Acinetobacter spp.
Response
13
80
M
21
Sternotomy, ARDS
VAP
Acinetobacter spp.
Response
14
43
M
19
Trauma
VAP
Acinetobacter spp.
Response
15
28
F
24
Morbid obesity, bowel resection
VAP
Acinetobacter spp.
No response, death
16
20
F
17
Trauma
Post-traumatic meningitis
Acinetobacter spp.
Response





Sinusitis
P. aeruginosa






Urosepsis
P. aeruginosa

17
61
M
20
Trauma
Catheter-related sepsis
P. aeruginosa
Response
18
35
M
14
Trauma
Catheter-related sepsis
P. aeruginosa
Response
19
62
M
29
Trauma, MOF (two organs), CVVHD
Catheter-related sepsis
P. aeruginosa
No response, death
20
64
F
28
Burns, MOF (two organs), CVVHD
Sepsis of unknown primary origin
P. aeruginosa
No response, death
21
73
M
32
Cancer of the colon, bowel resection, MOF (four organs)
Sepsis of unknown primary origin
P. aeruginosa
Initial response, death








22
29
M
14
Trauma
Sepsis of unknown primary origin
P. aeruginosa
Response
23
20
M
22
Trauma, crush syndrome, CVVHD
Empyema thoracis
P. aeruginosa
No response, death
24
74
M
28
Aneurysm of the abdominal aorta, elective operation
Sepsis of unknown primary origin
Acinetobacter spp.
Initial response, death

F, female; M, male; MOF, multiple organ failure; CVVHD, continuous venovenous hemodiafiltration.

Markou et al. Critical Care 2003 7:R78   doi:10.1186/cc2358